Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial

Jenny F. Seligmann, Alexandra Wright‐Hughes, A. Pottinger, Galina Velikova, Jamie B. Oughton, Geraldine Murden, Mohammed Rizwanullah, C. H. G. Price, Helen Passant, Peter Heudtlass, Helen Marshall, Stephen Johnston, David Dodwell